Antiarrhythmic properties of taurhythman were demonstrated on experimental models of ventricular (early occlusion and calcium chloride-induced) and atrioventricular (aconitine-induced) arrhythmias. The preparation reduced or prevented episodes of paroxysmal tachycardia and ventricular fibrillation, decreased the incidence of arrhythmias, and increased the lethal dose (LD) of arrhythmogenic agents. By its efficiency, taurhythman was superior to procainamide and comparable to lidocaine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10517-006-0015-5 | DOI Listing |
Publication Analysis
Top Keywords
antiarrhythmic activity
4
activity taurhythman
4
taurhythman antiarrhythmic
4
antiarrhythmic properties
4
properties taurhythman
4
taurhythman demonstrated
4
demonstrated experimental
4
experimental models
4
models ventricular
4
ventricular early
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!